Literature DB >> 19219077

Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis.

M Reinwald, L Uharek, D Lampe, T Grobosch, E Thiel, S Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19219077     DOI： 10.1038/bmt.2009.17

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.

Authors:  François Barde; Eliane Billaud; Lauriane Goldwirt; Catherine Horodyckid; Vincent Jullien; Fanny Lanternier; Philippe Lesprit; Lucie Limousin; Jérémie F Cohen; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Isavuconazole treatment of a patient with disseminated mucormycosis.

Authors:  Driele Peixoto; Lisa S Gagne; Sarah P Hammond; Erin T Gilmore; Amy C Joyce; Robert J Soiffer; Francisco M Marty
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

Review 3.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

4.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

5.  Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle.

Authors:  Eric Rhoden; Terry Fei Fan Ng; Ray Campagnoli; W Allan Nix; Jennifer Konopka-Anstadt; Rangaraj Selvarangan; Laurence Briesach; M Steven Oberste; William C Weldon
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 6.  Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications.

Authors:  Royce Johnson; Jackie Ho; Pete Fowler; Arash Heidari
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-13       Impact factor: 5.081

Review 7.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

8.  Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.

Authors:  Dionissios Neofytos; Edina Avdic; Anna-Pelagia Magiorakos
Journal:  Drug Healthc Patient Saf       Date:  2010-04-20

9.  Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.

Authors:  Stefan Schwartz; Oliver A Cornely; Kamal Hamed; Francisco M Marty; Johan Maertens; Galia Rahav; Raoul Herbrecht; Werner J Heinz
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

Review 10.  Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.

Authors:  Zorica Jović; Slobodan M Janković; Dejana Ružić Zečević; Dragan Milovanović; Srđan Stefanović; Marko Folić; Jasmina Milovanović; Marina Kostić
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.569
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.